Picture of Lonza AG logo

LONN — Lonza AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Lonza Expects Sales In H2 2025 To Be Higher Than In H1

July 23 (Reuters) - LONZA GROUP AG LONN.S:

H1 SALES GROWTH 19%

CHI FY 2025 OUTLOOK CONFIRMED AT LOW-TO-MID SINGLE-DIGIT CER GROWTH

H1 2025 SALES CHF 3.6 BILLION, CER GROWTH 19.0%

CDMO OUTLOOK FOR FY 2025 UPGRADED TO CER SALES GROWTH OF 20-21% (PREVIOUS "APPROACHING 20%") AND A CORE EBITDA MARGIN OF 30-31% (PREVIOUS "APPROACHING 30%")

CHI OUTLOOK FOR FY 2025 CONFIRMED

BUSINESS EXPECTS NO MATERIAL FINANCIAL IMPACT FROM US TRADE POLICIES

LONZA EXPECTS SALES IN H2 2025 TO BE HIGHER THAN IN H1 WITH CORE EBITDA MARGIN AT A SIMILAR LEVEL IN H1 AND H2

MADE GOOD PROGRESS IN H1 2025 WITH THE INTERNAL PREPARATIONS TO CARVE OUT AND EXIT THE CHI BUSINESS

Further company coverage: LONN.S

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Lonza AG

See all news